GeneQuine Biotherapeutics Raises Over Euro 9M in Series A and Non-Dilutive Funding

16 Feb, 2021

GeneQuine Biotherapeutics Raises Over Euro 9M in Series A and Non-Dilutive Funding
Photo by Farzad Nazifi on Unsplash

– GeneQuine is a Hamburg, Germany-based biotech company focused on the development of gene therapy for musculoskeletal disorders.
– The company raised a total of €9.05m in Series A and non-dilutive funding.
– The round was led by Pacira BioSciences, Inc. (Nasdaq: PCRX), with participation from High-Tech Gründerfonds, Noshaq SA, and Samum Vermögensverwaltungs GmbH.

Biopharma Biotechnology Developer Tools Europe Health Care
Crunchbase icon

Content report

The following text will be sent to our editors: